The present study has implicated that RES could inhibit MMP1 and MMP13 in MCC and increase the expression of cartilage markers ACAN and COL2 in vitro, which is one of the mechanism responsible for RES therapeutic effect. The gene discussed is ACAN; the disease is Merkel cell skin cancer.